Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021

CoVPN 3006 Study Team, Kathryn E Stephenson, Jasmine R Marcelin, Audrey E Pettifor, Holly Janes, Elizabeth Brown, Moni Neradilek, Catherine Yen, Jessica Andriesen, Nicole Grunenberg, Nicole Espy, Meg Trahey, Rebecca S B Fischer, Christopher A DeSouza, Joanna L Shisler, Elizabeth Connick, Eric R Houpt, Helen Y Chu, Russel J McCulloh, Sylvia Becker-DrepsNadja A Vielot, Corey A Kalbaugh, Kartik Cherabuddi, Karen M Krueger, Molly Rosenberg, Richard N Greenberg, Arnel Joaquin, Lilly Cheng Immergluck, Lawrence Corey

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021'. Together they form a unique fingerprint.

Medicine & Life Sciences